Catalyst Wire Dossier Catalyst Wire Dossier

ADYNOVATE

efmoroctocog alfa · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ADYNOVATE, covering 2025-02-04 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

See pricing